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The following abstracts are part of an ongoing series of
articles produced by the Cochrane Collaborative Review
Group on Peripheral Vascular Diseases, which is part of
The Cochrane Collaboration. The reviews are published in
full on The Cochrane Library, a quarterly electronic journal
available on CD-ROM and via the internet. The electronic
format allows Cochrane reviews to accommodate new
data as they become available, making the library a
consistently up-to-date source of information over time.
Certain abstracts appearing on The Cochrane Library
may be presented in a simpler, less scientific format
than the abstract presented here to permit greater
accessibility to the public. However, the substance of
both versions is the same. Cochrane reviews are now
indexed on MEDLINE.
If you are interested in conducting a Cochrane
review or contributing to the activities of the Cochrane
Collaborative Review Group on Peripheral Vascular
Diseases, please contact:
Professor FGR Fowkes





Edinburgh EH8 9AG, UK
Tel.: C44 131 650 3220
Fax: C44 131 650 6904.
Any comments or criticisms on Cochrane reviews/
abstracts should be made through the comments/
criticisms facility on The Cochrane Library, or by
contacting the group at the above address.0457 + 04 $35.00/0 q 2005 Elsevier Ltd. All rights reserAbstracts
Abstract. Cerebrospinal fluid drainage for thoracic
and throacoabdominal aortic aneurysm surgery.
Khan SN, Stansby G
First Published: The Cochrane Library Issue 1, 2004Background
During aortic aneurysm surgery, cross-clamping can
lead to inadequate blood supply to the spinal cord
resulting in neurological deficit. Cerebrospinal fluid
drainage (CSFD) may increase the perfusion pressure
to the spinal cord and hence reduce the risk of
ischaemic spinal cord injury.Objectives
To determine the effect of CSFD during thoracic and
thoracoabdominal aortic aneurysm (TAAA) surgery
on the risk of developing spinal cord injury.Search Strategy
The reviewers searched the Cochrane Peripheral
Vascular Diseases Group trials register (last searched
July 2004), the Cochrane Central Register of Controlled
Trials (CENTRAL) database (last searched The
Cochrane Library Issue 2, 2004). Reference lists of
relevant articles and recent conference proceedings
were scanned.Eur J Vasc Endovasc Surg 30, 457–460 (2005)
doi:10.1016/j.ejvs.2005.06.024, available online at http://www.sciencedirect.com onved.
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Randomised controlled trials involving CSFD during
thoracic and TAAA surgery.Data Collection and Analysis
Both reviewers assessed the quality of trials indepen-
dently. SNK extracted data and GS verified the data.Main Results
Three trials with a total of 287 participants operated on
for type I or II TAAA were included.
In the first trial of 98 participants, neurological
deficits in the lower extremities occurred in 14 (30%) in
CSFD group and 17 (33%) controls. The deficit was
observed within 24 h of the operation in 21 (68%), and
from 3 to 22 days in 10 (32%) participants. CSFD did
not have a significant benefit in preventing ischaemic
injury to the spinal cord.
The second trial of 33 participants used a combi-
nation of CSFD and intrathecal papaverine. It showed
a statistically significant reduction in the rate of
postoperative neurological deficit (P 0.039), compared
to controls. Analysis was undertaken after only one
third of the estimated sample size had entered the trial.
In the third trial TAAA repair was performed on 145
participants. CSFD was initiated during the operation
and continued for 48 h after surgery. Paraplegia or
paraparesis occurred in 9 of 74 participants (12.2%) in
the control group versus 2 of 82 participants (2.7%)
receiving CSFD (P 0.03). Overall, CSFD resulted in an
80% reduction in the relative risk of postoperative
deficits. Meta-analysis showed an odds ratio (OR) of
0.48 (95% confidence interval (CI) 0.25 to 0.92). For
CSFD-only trials, OR was 0.57 (95% CI 0.28 to 1.17) and
for intention-to-treat analysis in CSFD-only studies,
the OR remained unchanged.Reviewers’ Conclusions
There are limited data supporting the role of CSFD in
thoracic and thoracoabdominal aneurysm surgery for
prevention of neurological injury. Further clinical and
experimental studies are indicated.
Abstract. Infusion techniques for peripheral
arterial thrombolysis.
Kessel DO, Berridge DC, Robertson I
First Published: The Cochrane Library Issue 1, 2004Eur J Vasc Endovasc Surg Vol 30, 11 2005Background
Thrombolytic therapy is a useful tool in the manage-
ment of acute peripheral arterial ischaemia. Fibrino-
lytic drugs are used to disperse blood clot to clear
arterial occlusion. A variety of techniques are used to
deliver these agents.Objectives
To determine the optimal technique for infusion of
fibrinolytic drugs in peripheral arterial ischaemia.Search Strategy
The reviewers searched the Cochrane Peripheral
Vascular Diseases Group Specialised Trials Register
(last searched July 2003) and the Cochrane Central
Register of Controlled Trials (CENTRAL) database
(last searched The Cochrane Library Issue 3, 2003).
Proceedings from meetings of British, European and
North American Vascular Surgical and Radiological
Societies, plus reference lists of identified studies were
also searched for relevant trials. Major pharmaceutical
firms and trialists were asked about unpublished
trials.Selection Criteria
Two reviewers independently selected randomised
controlled trials comparing infusion techniques of
fibrinolytic agents in the treatment of acute peripheral
arterial ischaemia. Trials with poor quality method-
ology were excluded.Data Collection and Analysis
Data from included trials were collated and analysed
for the following outcomes: Limb salvage, amputation,
death, vessel patency, time to achieve thrombolysis,
and reduction in the need for surgical intervention.
Complication rates were compared for: Major haem-
orrhage, cerebrovascular accident and distal
embolization.Main Results
Intra-arterial delivery of thrombolytic agents appeared
to be more effective than intravenous administration.
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graphic catheter was placed within the thrombus.
Although ‘high dose’ and ‘forced infusion’ techniques
achieved vessel patency in less time than ‘low dose
infusion’, there were more bleeding complications,
and no increase in patency rates or improvement in
limb salvage at 30 days.Reviewers’ Conclusions
Implications for practice
† Thrombolysis should be reserved for patients with
limb threatening ischaemia, due to the high risk of
haemorrhage or death.
† Greater benefit is seen when the thrombolytic agent
is delivered into the thrombus. Systemic intrave-
nous thrombolysis is less effective than intra-
arterial thrombolysis and is associated with an
increase in bleeding complications.
† ‘High dose’ and ‘forced infusion’ techniques, or
adjunctive agents such as platelet glycoprotein
IIb/IIIa inhibitors may speed up thrombolysis,
but these are not accompanied by lower amputa-
tion rates or a decreased need for adjunctive
endovascular or surgical procedures.
† ‘Low dose continuous infusion’, following initial
lacing of the thrombus with a high dose of the
thrombolytic agent, is the least labour intensive
technique.
Implications for research
† Only large multicentre trials with carefully con-
trolled inclusion criteria will be sufficiently power-
ful to demonstrate genuine benefit for a particular
thrombolytic regime.
Abstract. Prostanoids for intermittent
claudication.
Reiter M, Bucek RA, Stu¨mpflen A, Minar E
First Published: The Cochrane Library Issue 1, 2004Background
Peripheral arterial occlusive disease (PAOD) is a
common cause of morbidity in the general population.
While numerous studies have established the efficacy
of prostanoids in PAOD stages III and IV the question
of the role of prostanoids as an alternative or additive
treatment in patients suffering from claudicatiointermittens (PAOD II) has not yet been clearly
answered.Objectives
The aim of this review was to evaluate effects of
prostanoids in patients with intermittent claudication.Search Strategy
Computerised searches of the Cochrane Peripheral
Vascular Diseases Specialized Register (last searched
July 2004), The Cochrane Central Register of Con-
trolled Trials (CENTRAL) (last searched The Cochrane
Library Issue 2, 2004), MEDLINE and EMBASE were
undertaken. In addition relevant journals were
handsearched.Selection Criteria
Randomized clinical trials describing the effects of
prostanoids in the treatment of patients suffering from
intermittent claudication were considered for
inclusion.Data Collection and Analysis
All reviewers assessed the quality of studies and
extracted data unblinded. Statistical analysis includ-
ing tests for heterogeneity and overall effect were
performed by using MetaView of Review Manager 4.2.
All numeric values are expressed as mean G standard
deviation (SD).Main Results
Eighteen studies were included for analysis. A
significant heterogeneity between the included studies
was detected in most of the subgroup analysis. Five
studies compared the effects of prostaglandin E1
(PGE1) versus placebo, and reported in their individ-
ual results significant increases in walking distances
after the administration of PGE1. The attained increase
in walking distances appears to be not merely a short-
term effect because several studies reported that
walking capacity remained increased even after
termination of treatment. On the other hand, oral or
intravenous prostacyclin did not increase the walking
distances significantly.Eur J Vasc Endovasc Surg Vol 30, 11 2005
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23.6% of the participants treated with prostacyclin
(PGI2), and its analogues and from 13.7% of the
participants treated with PGE1.Reviewers’ Conclusions
Because of the heterogeneity between most of the
included studies, we did not pool relevant parts of the
data by meta-analysis. Based on the individual results
of the published literature, patients with intermittent
claudication seem to benefit from administration
(intravenous or intra-arterial) of PGE1 by a significant
improvement of their walking capacity. Further well-
conducted randomized, double blinded trials, with a
sufficient number of participants to provide statistical
powerful information, should be performed to confirm
the results of this review.
Abstract. Type of skin incision for below knee
amputation.
Tisi PV, Callam MJ
First Published: The Cochrane Library Issue 1, 2004Background
Below knee amputation (BKA) may be necessary in
patients with advanced critical limb ischaemia or
diabetic foot sepsis in whom no other treatment option
is available. There is no consensus as to which surgical
technique achieves the maximum rehabilitation
potential.Objectives
To look at the evidence comparing different surgical
techniques for BKA using stump healing, wound
infection, reamputation rate and mobility with a
prosthetic limb as outcome measures.Search Strategy
Publications describing randomised controlled trials
comparing different types of incision for below knee
amputation were sought using the search strategy
described by the Cochrane Review Group onEur J Vasc Endovasc Surg Vol 30, 11 2005Peripheral Vascular Diseases. This involved searching
the Cochrane Central Register of Controlled Trials
(CENTRAL), MEDLINE and EMBASE. Additional
searches were made of bibliographies of papers
found through these searches, and also by handsearch-
ing relevant journals.Selection Criteria
Randomised controlled trials comparing two or more
types of skin incision for BKA were identified. All
patients with lower limb ischaemia (acute or chronic)
and/or diabetic foot sepsis were considered for
inclusion. Patients undergoing below knee amputa-
tion for other conditions were excluded.Data Collection and Analysis
Three studies were included in the analysis: two-stage
versus one-stage BKA; skew flaps BKA versus long
posterior flap BKA; sagittal flaps BKA versus long
posterior flap BKA. Data were extracted indepen-
dently by both authors.Main Results
BKA using skew flaps or sagittal flaps conferred no
advantage over the well established long posterior flap
technique. For patients with wet gangrene, a two-stage
procedure with a guillotine amputation at the ankle
followed by a definitive long posterior flap amputa-
tion leads to better primary stump healing than a one-
stage procedure.Reviewers’ Conclusions
Evidence suggests that the choice of amputation
technique has no effect on outcome and can therefore
be a simple matter of surgeon preference. Factors
which might influence this include previous experi-
ence of a particular technique, the extent of non-viable
tissue, and the location of pre-existing surgical scars.
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